{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:23:06Z","timestamp":1788870186497,"version":"build-2803163510"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ursula Brain"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Women's Health Research Institute and Neurodevnet"}],"content-domain":{"domain":["bestpracticeobgyn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.bpobgyn.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T14:06:27Z","timestamp":1379513187000},"page":"37-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["The effect of perinatal exposures on the infant: Antidepressants and depression"],"prefix":"10.1016","volume":"28","author":[{"given":"Gillian E.","family":"Hanley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim F.","family":"Oberlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2013.09.001_bib1","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2007.01.033","article-title":"Increasing use of antidepressants in pregnancy","volume":"196","author":"Cooper","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib2","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","article-title":"Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data","volume":"63","author":"Oberlander","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clinthera.2011.11.025","article-title":"Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001\u20132006)","volume":"34","author":"Daw","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00023210-200923060-00004","article-title":"Safety of selective serotonin reuptake inhibitors in pregnancy","volume":"23","author":"Alwan","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1345\/aph.1E547","article-title":"Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis","volume":"39","author":"Hemels","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajog.2012.02.009","article-title":"Antidepressant use during pregnancy: the benefit-risk ratio","volume":"207","author":"Koren","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0030-1262507","article-title":"Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors","volume":"28","author":"Wilson","year":"2011","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/acps.12042","article-title":"Antidepressant use in pregnancy: a critical review focused on risks and controversies","volume":"127","author":"Byatt","year":"2013","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib9","first-page":"20","article-title":"Maternal stress or anxiety during pregnancy and the development of the baby","volume":"2","author":"Glover","year":"1999","journal-title":"Pract Midwife"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.AOG.0000135277.04565.e9","article-title":"Implications of antenatal depression and anxiety for obstetric outcome","volume":"104","author":"Andersson","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/nur.1023","article-title":"Relationships among maternal\u2013fetal attachment, prenatal depression, and health practices in pregnancy","volume":"24","author":"Lindgren","year":"2001","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2125.2005.02538.x","article-title":"Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding","volume":"61","author":"Kim","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tips.2009.11.003","article-title":"New perspectives on the neurodevelopmental effects of SSRIs","volume":"31","author":"Homberg","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib14","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nrn1256","article-title":"The developmental role of serotonin: news from mouse molecular genetics","volume":"4","author":"Gaspar","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/clpt.2009.201","article-title":"Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence","volume":"86","author":"Oberlander","year":"2009","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib16","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1176\/appi.ajp.158.10.1728","article-title":"Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study","volume":"158","author":"Einarson","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib17","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/01.AOG.0000187302.61812.53","article-title":"Risks associated with selective serotonin reuptake inhibitors in pregnancy","volume":"106","author":"Malm","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib18","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/00006842-200109000-00017","article-title":"Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes","volume":"63","author":"Chung","year":"2001","journal-title":"Psychosom Med"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/da.10071","article-title":"Pregnancy anxiety and comorbid depression and anger: effects on the fetus and neonate","volume":"17","author":"Field","year":"2003","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib20","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archgenpsychiatry.2010.111","article-title":"A\u00a0meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction","volume":"67","author":"Grote","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/aje\/155.4.293","article-title":"Role of anxiety and depression in the onset of spontaneous preterm labor","volume":"155","author":"Dayan","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1037\/0278-6133.19.6.535","article-title":"Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women","volume":"19","author":"Hoffman","year":"2000","journal-title":"Health Psychol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/aje\/kwf131","article-title":"Maternal prenatal depressive symptoms and spontaneous preterm births among African\u2013American women in Baltimore, Maryland","volume":"156","author":"Orr","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0895-4356(92)90149-H","article-title":"Self-reported depression and negative pregnancy outcomes","volume":"45","author":"Steer","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmj.318.7177.153","article-title":"Association between maternal anxiety in pregnancy and increased uterine artery resistance","volume":"318","author":"Teixera","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1469-7610.2011.02371.x","article-title":"Annual research review: prenatal stress and the origins of psychopathology: an evolutionary perspective","volume":"52","author":"Glover","year":"2011","journal-title":"J\u00a0Child Psychol Psyc"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/0167482X.2010.544427","article-title":"Associations of maternal psychological factors with umbilical and uterine blood flow","volume":"32","author":"Mendelson","year":"2011","journal-title":"J\u00a0Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0029-7844(95)00118-B","article-title":"Maternal weight gain pattern and birth weight","volume":"86","author":"Abrams","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0163-6383(01)00066-2","article-title":"Depressed withdrawn and intrusive mothers' effects on their fetuses and neonates","volume":"24","author":"Field","year":"2001","journal-title":"Infant Behav Dev"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0163-6383(96)90003-X","article-title":"Newborns of mothers with depressive symptoms are less expressive","volume":"19","author":"Lundy","year":"1996","journal-title":"Infant Behav Dev"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib31","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/070674370404901006","article-title":"Relation between prenatal maternal mood and anxiety and neonatal health","volume":"49","author":"Misri","year":"2004","journal-title":"Can J Psychiat"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1467-8624.2004.00727.x","article-title":"High antenatal maternal anxiety is related to ADHD symptoms, externalizing problems, and anxiety in 8- and 9-year olds","volume":"75","author":"Van den Bergh","year":"2004","journal-title":"Child Dev"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00004703-199008000-00006","article-title":"Maternal depressive symptoms during pregnancy, and newborn irritability","volume":"11","author":"Zuckerman","year":"1990","journal-title":"J\u00a0Dev Behav Pediatr"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1207\/S15326942DN2003_6","article-title":"The effects of maternal depression on fetal heart rate response to vibroacoustic stimulation","volume":"20","author":"Allister","year":"2001","journal-title":"Dev Neuropsychol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1098-2302(200001)36:1<67::AID-DEV7>3.0.CO;2-C","article-title":"Maternal stress responses and anxiety during pregnancy: effects on fetal heart rate","volume":"36","author":"Monk","year":"2000","journal-title":"Dev Psychobiol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1469-7610.2006.01714.x","article-title":"Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?","volume":"48","author":"Talge","year":"2007","journal-title":"J\u00a0Child Psychol Psyc"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/070674371205700901","article-title":"A\u00a0tale of 2s: optimizing maternal-child health in the context of antenatal maternal depression and antidepressant use","volume":"57","author":"Oberlander","year":"2012","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib38","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1176\/appi.ajp.2007.06111893","article-title":"Clinically identified maternal depression before, during, and after pregnancies ending in live births","volume":"164","author":"Dietz","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib39","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/aje\/kwh122","article-title":"Neonatal outcome following maternal antenatal depression and anxiety: a population-based study","volume":"159","author":"Andersson","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00737-005-0090-z","article-title":"Neonatal outcomes in offspring of women with anxiety and depression during pregnancy","volume":"8","author":"Berle","year":"2005","journal-title":"Arch Women Ment Health"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.AOG.0000136087.46864.e4","article-title":"Health, sociodemographic data, and pregnancy outcome in women with antepartum depressive symptoms","volume":"104","author":"Larsson","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1471-0528.1993.tb14228.x","article-title":"The effect of anxiety and depression during pregnancy on obstetric complications","volume":"100","author":"Perkin","year":"1993","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib43","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1067\/mob.2002.127126","article-title":"Mood disturbance in pregnancy and the mode of delivery","volume":"187","author":"Wu","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14767050701209560","article-title":"Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature","volume":"20","author":"Alder","year":"2007","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib45","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0002-9378(98)70214-5","article-title":"Preterm birth and maternal smoking: risks related to gestational age and onset of delivery","volume":"179","author":"Kyrklund-Blomberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib46","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jama.2009.201","article-title":"Association between diabetes and perinatal depression among low-income mothers","volume":"301","author":"Kozhimannil","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib47","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/aje\/145.8.689","article-title":"Effect of uncomplicated chronic hypertension on the risk of small-for-gestational age birth","volume":"145","author":"Haelterman","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0029-7844(99)00602-X","article-title":"Depression and anxiety in early pregnancy and risk for preeclampsia","volume":"95","author":"Kurki","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0029-7844(02)02014-8","article-title":"Psychiatric and substance use disorders as risk factors for low birth weight and preterm delivery","volume":"100","author":"Kelly","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib50","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/EDE.0b013e3182306847","article-title":"Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?","volume":"22","author":"Yonkers","year":"2011","journal-title":"Epidemiology"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2008.06.017","article-title":"Complementary and alternative medicine for perinatal depression","volume":"112","author":"Freeman","year":"2009","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib52","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/bdrb.20099","article-title":"First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage","volume":"80","author":"B\u00e9rard","year":"2007","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib54","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1503\/cmaj.091208","article-title":"Use of antidepressants during pregnancy and the risk of spontaneous abortion","volume":"182","author":"Nakhai-Pour","year":"2010","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/bdrb.20144","article-title":"Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data","volume":"83","author":"Oberlander","year":"2008","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib56","doi-asserted-by":"crossref","first-page":"b3569","DOI":"10.1136\/bmj.b3569","article-title":"Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study","volume":"339","author":"Pedersen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bdra.20627","article-title":"First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies","volume":"88","author":"Wurst","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib58","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1067\/mpd.2003.139","article-title":"Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy","volume":"142","author":"Casper","year":"2003","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib59","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1023\/A:1025306304635","article-title":"Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics","volume":"18","author":"Mortensen","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib60","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1542\/peds.2008-3655","article-title":"Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age","volume":"125","author":"Pedersen","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1203\/00006450-200204000-00008","article-title":"Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response","volume":"51","author":"Oberlander","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib62","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archgenpsychiatry.2011.73","article-title":"Antidepressant use during pregnancy and childhood autism spectrum disorders","volume":"68","author":"Croen","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib63","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM199701233360404","article-title":"Neurodevelopment of children exposed in utero to antidepressant drugs","volume":"336","author":"Nulman","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib64","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1176\/appi.ajp.159.11.1889","article-title":"Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study","volume":"159","author":"Nulman","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib65","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":"Birth outcomes in pregnant women taking fluoxetine","volume":"335","author":"Chambers","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","article-title":"Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants","volume":"160","author":"Levinson-Castiel","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib67","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":"Neonatal signs after late in utero exposure to serotonin reuptake inhibitors","volume":"293","author":"Moses-Kolko","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib68","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1176\/appi.ajp.2008.08081170","article-title":"Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes","volume":"166","author":"Wisner","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib69","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/pds.1462","article-title":"Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy","volume":"16","author":"Davis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib70","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2125.2008.03261.x","article-title":"Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study","volume":"66","author":"Diav-Citrin","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib71","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archpedi.156.11.1129","article-title":"Perinatal outcome following third trimester exposure to paroxetine","volume":"156","author":"Costei","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib72","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","article-title":"Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations","volume":"60","author":"Laine","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib73","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archpedi.158.4.312","article-title":"Neonate characteristics after maternal use of antidepressants in late pregnancy","volume":"158","author":"Kallen","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib74","first-page":"449","article-title":"Antidepressant discontinuation syndrome","volume":"74","author":"Warner","year":"2006","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib75","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4088\/JCP.v65n0214","article-title":"Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure","volume":"65","author":"Oberlander","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib76","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00004714-199610000-00003","article-title":"Serotonin reuptake inhibitor withdrawal","volume":"16","author":"Coupland","year":"1996","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib77","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1542\/peds.2009-0442","article-title":"Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors","volume":"124","author":"Pawluski","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib78","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1203\/PDR.0b013e318193594a","article-title":"Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes","volume":"65","author":"Davidson","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib79","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.euroneuro.2009.01.006","article-title":"MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs","volume":"19","author":"Hilli","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib80","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archpedi.161.1.22","article-title":"Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy","volume":"161","author":"Oberlander","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib81","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/jp.2010.211","article-title":"Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome","volume":"31","author":"Klinger","year":"2011","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib82","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0893-133X(00)00132-9","article-title":"Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression","volume":"23","author":"Pollock","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib83","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.mp.4002007","article-title":"Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications","volume":"13","author":"Oberlander","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib84","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0006-3223(00)00877-5","article-title":"Birth outcomes following prenatal exposure to fluoxetine","volume":"48","author":"Cohen","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib85","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/070674371205700902","article-title":"Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors","volume":"57","author":"Shea","year":"2012","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib86","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1017\/S003329170600835X","article-title":"To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects","volume":"36","author":"Austin","year":"2006","journal-title":"Psychol Med"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib87","first-page":"107","article-title":"Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome","volume":"45","author":"Klinger","year":"2008","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib88","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/pds.1463","article-title":"Paroxetine in the first trimester and the prevalence of congenital malformations","volume":"16","author":"Cole","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib89","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bdra.20327","article-title":"Maternal use of selective serotonin reuptake inhibitors in early pregnancy and infant congenital malformations","volume":"79","author":"K\u00e4ll\u00e9n","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib90","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.ede.0000239581.76793.ae","article-title":"Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations","volume":"17","author":"Wogelius","year":"2006","journal-title":"Epidemiology"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib91","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1001\/jama.1993.03500170076037","article-title":"Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)","volume":"269","author":"Pastuszak","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib92","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.279.8.609","article-title":"Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors","volume":"279","author":"Kulin","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bpobgyn.2013.09.001_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001148","article-title":"Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study","volume":"2","author":"Jimenez-Solem","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib94","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/157488610790936114","article-title":"Antidepressant use during pregnancy: a critical systematic review of the literature","volume":"5","author":"Simoncelli","year":"2010","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib95","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1701-2163(15)30965-8","article-title":"The fetal safety of fluoxetine: a systematic review and meta-analysis","volume":"35","author":"Riggin","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib96","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1542\/peds.111.3.451","article-title":"Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns","volume":"111","author":"Koppel","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib97","first-page":"359","article-title":"Mortality among infants with congenital malformations, New York State, 1983 to 1988","volume":"111","author":"Druschel","year":"1996","journal-title":"Public Health Rep"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib98","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00431-010-1160-4","article-title":"Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine\u2014results from a prospective multicenter study","volume":"169","author":"Riede","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib99","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/S0140-6736(12)60107-X","article-title":"Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis","volume":"379","author":"Thangaratinam","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0095-5108(18)30039-3","article-title":"Pulmonary vascular biology during neonatal transition","volume":"26","author":"Lakshminrusimha","year":"1999","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib101","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.pcl.2009.04.004","article-title":"Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn","volume":"56","author":"Konduri","year":"2009","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib102","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pds.1570","article-title":"Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn","volume":"17","author":"K\u00e4ll\u00e9n","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib103","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib104","doi-asserted-by":"crossref","first-page":"d8012","DOI":"10.1136\/bmj.d8012","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries","volume":"344","author":"Kieler","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.1710","article-title":"Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn","volume":"18","author":"Andrade","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib106","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.reprotox.2012.04.015","article-title":"Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN): a systematic review","volume":"34","author":"Jong","year":"2012","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib107","series-title":"Nelson textbook of pediatrics","first-page":"552","article-title":"The high-risk infant","author":"Carlo","year":"2011"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib108","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/00006450-199306000-00024","article-title":"Monitoring neonatal peripheral circulation by electrocardiogram-to-oximeter pulse velocity","volume":"33","author":"Oishi","year":"1993","journal-title":"Pediatr Res"},{"key":"10.1016\/j.bpobgyn.2013.09.001_bib109","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.genhosppsych.2009.04.003","article-title":"The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists","volume":"31","author":"Yonkers","year":"2009","journal-title":"Gen Hosp Psychiatry"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693413001314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693413001314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:21:37Z","timestamp":1715973697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693413001314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1521693413001314"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2013.09.001","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of perinatal exposures on the infant: Antidepressants and depression","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}